Влияние глутамина на функциональное состояние кишечника у больных в критическом состоянии
https://doi.org/10.15360/1813-9779-2009-3-74
Аннотация
Не вызывает сомнения, что изменения со стороны желудочно-кишечного тракта играют важную роль в патогенезе развития инфекционных осложнений, сепсиса и способствуют возникновению синдрома полиорганной недостаточности. Была показана взаимосвязь между проницаемостью кишечной стенки и частотой возникновения осложнений, включая развитие тяжелого сепсиса у больных в критических состояниях. В настоящем обзоре представлены основные механизмы, способствующие нарушению целостности кишечного барьера и возможности использования экзогенного глутамина для коррекции возникающих нарушений. Ключевые слова: транслокация бактерий, сепсис, тяжелый сепсис, глутамин, энтеральное питание.
Список литературы
1. Marshall J. C., Chirstou N. V., Meakins J. L.
2. Deitch E. A.Role of the gut lymphatic system in multiple organ failure. Curr. Opin. Crit. Care 2001; 7 (2): 92—98.
3. Zigler T.R.,Smith R.J., O‘DwyerS.T. et al.Increased intestinal permeability associated with infection in burn patients. Arch. Surg. 1988; 123 (11): 1313—1319.
4. Deitch E. A.Intestinal permeability in increased in burn patients shortly after injury. Surgery 1990; 107 (4): 411—416.
5. Le Voyer T., Cioffi W.G.,Piatt L. et al.Alterations in intestinal permeability after thermal injury. Arch. Surg. 1992; 127 (1): 26—30.
6. Faries P.L.,Simon R.J.,Martella A. T. et al.Intestinal permeability correlates with severity of injury in trauma patients. J. Trauma 1998; 44 (6): 1031—1035.
7. Doig C.J.,SutherlandL.R.,SandhamJ. D. et al.Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am. J. Respir. Crit. Care Med. 1998; 158 (2): 444—451.
8. Marchall J. C., Cook D. J., Christou N. V. et al.Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit. Care Med. 1995; 23 (10): 1638—1652.
9. Goris R. J., te Boekhorst T. P., Nuytinck J. K., Gimbrere J. S.Multiple organ failure. Generalized autodestructive inflammation? Arch. Surg. 1985; 120 (10): 1109—1115.
10. Swank G. M., Deitch E. A.Role of the gut in multiple organ failure. Bacterial translocation and permeability changes. World J. Surg. 1996; 20 (4): 411—417.
11. Lipman T. O.Bacterial translocation and enteral nutrition in humans: An outsider looks in. J. Parenter. Enteral. Nutr. 1995; 19 (2): 156—165.
12. Moore F. A.The role of the gastrointestinal tract in postinjury multiple organ failure. Am. J. Surg. 1999; 178 (6): 449—453.
13. Deitch E. A. Bacterial translocation or lymphatic drainage of toxic products fromthe gut: What is important in human beings? Surgery 2002; 131 (3): 241—244.
14. Riddington D. W., Venkatesh B., Boivin C. M. et al.Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. JAMA 1996; 275 (13): 1007—1012.
15. Rush B. F., Sori A. J., Muphy T. F. et al.Endotoxemia and bacteremia during hemorrhagic shock. Ann. Surg. 1988; 207 (5): 549—554.
16. Deitch E. A.Simple intestinal obstruction causes bacterial translocation in man. Arch. Surg. 1989; 124 (6): 699—701.
17. Cicalese L., Sileri P., Green M. et al.Bacterial translocation in clinical intestinal transplantation. Transplant. Proc. 2000; 32 (6): 1210.
18. Welsh F. K., Farmery S. M., MacLennan K. et al.Gut barrier function in malnourished patients. Gut 1998; 42 (3): 396—401.
19. Keshavarzian A., Holmes E. W., Patel M. et al.Leaky gut in alcoholic cirrhosis: A possible mechanism for alcohol-induced liver damage. Am. J. Gastroenterol. 1999; 94 (1): 200—207.
20. Schweinburg F. B., Seligman A. M., Fine J.Transmural migration of intestinal bacteria; a study based on the use of radioactive Escherichia Coli. N. Engl. J. Med. 1950; 242 (19): 747—751.
21. Deitch E. A., Morrison J., Berg R., Specian R. D.Effect of hemorrhagic shock on bacterial translocation, intestinal morphology, and intestinal permeability in conventional and antibiotic-decontaminated rats. Crit. Care Med. 1990; 18 (5): 529—536.
22. Jones W. G., Minei J. P., Barber A. E. et al.Bacterial translocation and intestinal atrophy after thermal injury and burn wound sepsis. Ann. Surg. 1990; 211 (4): 399—405.
23. Gianotti L., Alexander J. W., Gennari R. et al.Oral glutamine decreases bacterial translocation and improves survival in experimental gut-origin sepsis. J. Parenter. Enteral Nutr. 1995; 19 (1): 69—74.
24. Wells C. L., Juni B. A., Cameron S. B. et al.Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant entero-cocci in hospitalized medical and/or surgical patients. Clin. Infect. Dis. 1995; 21 (1): 45—50.
25. Vincent J., Bihari D. J., Suter P. M. et al.The prevalence of nosocomial infection in intensive care units in Europe. Results of the European prevalence of infection in intensive care (EPIC) study. TAMA 1995; 274 (8): 639—644.
26. Sedman P. C., Macfie J., Sagar P. et al.The prevalence of gut transloca-tion in humans. Gastroenterology 1994; 107 (3): 643—649.
27. No authors listed. Selective decontamination of the digestive tract tri-alists’ Collaborative group: Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. BMJ 1993; 307 (6903): 525—532.
28. D ‘Amico R., Pifferi S., Leonetti C. et al.Effectiveness of antibiotic prophylaxis in critically ill adult patients: Systematic review of randomised controlled trials. BMJ 1998; 316 (7140): 1275—1285.
29. Zigler T. R., Evans M. E., Fernandez-Estivariz C., Jones D. P.Trophic and cytoprotective nutrition for intestinal adaptation, mucosal repair, and barrier function. Annu. Rev. Nutr. 2003; 23: 229—261.
30. Wiest R., Rath H. C.Bacterial translocation in the gut. Best Pract. Res. Clin. Gastroenterol. 2003; 17 (3): 397—425.
31. AlverdyJ. C., Laughlin R. S., Wu L.Influence of the critically ill state on host-pathogen interactions within the intestine: Gut-derived sepsis redefined. Crit. Care Med. 2003; 31 (2): 598—607.
32. Lyte M.Microbial endocrinology and infections disease in the 21st century. Trends Microbiol. 2004; 12 (1): 14—20.
33. Wu L., Hoolbrook C., Zaborina O. et al.Pseudomonas aeruginosa expresses a lethal virulence determinant, the PA-1 lectin/adhesion, in the intestinal tract of a stressed host. Ann. Surg. 2003; 238 (5): 754—764.
34. Rocha F., Laughlin R., Musch M. W. et al.Surgical stress shifts the intestinal Escherichia coli population to that of a more adherent phe-notype: Role in barrier regulation. Surgery 2001; 130 (1): 65—73.
35. Moore F. A., Moore E. E., Poggetti R. et al.Gut bacterial translocation via portal vein: A clinical perspective with major torso trauma. J. Trauma 1991; 31 (5): 629—638.
36. Feltis B. A., Kim A. S., Kinneberg K. M. et al.Clostridium difficile toxins may augment bacterial penetration of intestinal epithelium. Arch. Surg. 1999; 134 (11): 1235—1242.
37. Feltis B. A., Garni R. M., Wells C. L.Clostridium difficile toxins and entero-coccal translocationin vivoandin vitro.J. Surg. Res. 2001; 97 (1): 97—102.
38. Lemaire L. C., van Lanschot J. J., StoutenbeekС. P. et al.Bacterial translocation in multiple organ failure: Cause or epiphenomenon still unproven. Br. J. Surg. 1997; 84 (10): 1340—1350.
39. Olofsson P., Nyalander G., Olsson P.Endotoxin: Routes of transport in experimental peritonitis. Am. J. Surg. 1986; 151 (4): 443—446.
40. Deitch E. A., Forsythe R., Anjaria D. et al.The role of lymph factors in lung injury, bone marrow suppression, and endothelial cell dysfunction in a primate model of trauma-hemorrhagic shock. Shock 2004; 22 (3): 221—228.
41. Rombeau J. L., Takala J.Summary of round table conference: Gut dysfunction in critical illness. Intensive Care Med. 1997; 23 (4): 476—479.
42. Fukatsu K., Sakamoto S., Hara E. et al.Gut ischemia-reperfusion affects gut mucosal immunity: A possible mechanism for infectious complications after severe surgical insults. Crit. Care Med. 2006; 34 (1): 182—187.
43. Harris C. E., Griffiths R. D., Freestone N. et al.Intestinal permeability in critically ill. Intensive Care Med. 1992; 18 (1): 38—41.
44. JohanssonJ. E., Ekman T.Gastro-intestinal toxicity related to bone marrow transplantation: Disruption of the intestinal barrier precedes clinical findings. Bone Marrow Transplant. 1997; 19 (9): 921—925.
45. Alican I., Kubes P.A critical role for nitric oxide in intestinal barrier function and dysfunction. Am. J. Physiol. 1996; 270 (2 Pt 1): G225—G237.
46. Pastores S. M., Katz D. P., Kvetan V.Splanchic ischemia and gut mucos-al injury in sepsis and the multiple organ dysfunction syndrome. Am. J. Gastroenterol. 1996; 91 (9): 1697—1710.
47. Haglung U.Pathophysiology of gut dysfunction in shock and sepsis. In: Gut Dysfunction in Critical Illness. Rombeau J. L., Takala J. (eds.). Berlin, Springer-Verlag; 1996. 3—11.
48. Fink M. P.Inestinal mucosal hyperpermeability in critical illness. In: Gut Dysfunction in Critical Illness. Rombeau J. L., Takala J. (eds.). Berlin, Springer-Verlag; 1996. 12—24.
49. Parks D. A., Granger D. N.Ischemia-induced vascular changes. Role of xanthine oxidase and hydroxyl radicals. Am. J. Physiol. 1983; 245 (2): G285—G289.
50. ArRajad A., Dawidson I., Fabia R.Reperfusion injury. New Horiz. 1996; 4 (2): 224—234.
51. Kong S. E., Blennerhassett L. R., Heel K. A. et al.Ischaemia-reperfusion injury to the intestine. Aust. N. Z. J. Surg. 1998; 68 (8): 554—561.
52. Madara J. L.Regulation of the movement of solutes across tight junctions. Annu. Rev. Physiol. 1998; 60: 143—159.
53. Turner J. R., Rill B. K., Carlson S. L. et al.Physiological regulation of epithelial tight junctions is associated with myosin light-chain phos-phorylation. Am. J. Physiol. 1997; 273 (4 Pt 1): C1378—C1385.
54. Han X., Fink M. P., Yang R., Delude R. L.Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotox-emic mice. Shock 2004; 21 (3): 261—270.
55. Han X., Fink M. P., Uchiyama T. et al.Increased iNOS activity is essential for hepatic epithelial tight junction dysfunction in endotoxemic mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2004; 286 (1): G126—G136.
56. Han X., Fink M. P., Uchiyama T. et al.Increased iNOS activity is essential for pulmonary epithelial tight junction dysfunction in endotoxemic mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2004; 286 (2): L259—L267.
57. Rodriguez P., Heyman M., Candalh C. et al.Tumour necrosis factor-a induces morphological and functional alterations of intestinal HT29 c1. 19A cell monolayers. Cytokine 1995; 7 (5): 441—448.
58. Chavez A. M, Menconi M. J., Hodin R. A. et al.Cytokine—induced intestinal epithelial hyperpermeability. Role of nitric oxide. Crit. Care Med. 1999; 27 (10): 2246—2251.
59. Marik P. E., Iglesias J.Intestinal mucosal permeability: Mechanisms and implications for treatment. Crit. Care Med. 1999; 27 (8): 1650—1651.
60. Fink M. P.Modulating the L-arginine-nitric oxide pathway in the septic shock: Choosing the proper point of attack. Crit. Care Med. 1999; 27 (9): 2019—2022.
61. Banan A., Fields J. Z.., Decker H. et al.Nitric oxide and its metabolites mediate ethanol-induced microtubule disruption and intestinal barrier dysfunction. J. Pharmacol. Exp. Ther. 2000; 294 (3): 997—1008.
62. Castro L., Rodriguez M., Radi R.Aconitase is readily inactivated by per-oxynitrite, but not by its precursor, nitric oxide. J. Biol. Chem. 1994; 269 (47): 29409—29415.
63. Harward T. R., Coe D., Souba W. W. et al.Glutamine preserves gut glutathione levels during intestinal ischemia/reperfusion. J. Surg. Res. 1994; 56 (4): 351—355.
64. Jian Z. M., Cao J. D., Zhu X. G. et al.The impact of alanyl-glutamine on clinical safety, nitrogen balance, intestinal permeability, and clinical outcome in postoperative patients. A randomized, double-blind, controlled study of 120 patients. J. Parenter. Enteral Nutr. 1999; 23 (5 Suppl.): S62—S66.
65. Zhou Y. P., Jiang Z. M., Sun YH.The effect of supplemental enteral glu-tamine on plasma levels, gut function, and outcome in severe burns: A randomized, double-blind, controlled clinical trial. J. Parenter. Enteral Nutr. 2003; 27 (4): 241—245.
66. PengX., Yan H., You Z. et al.Effects of enteral supplementation with glu-tamine granules on intestinal mucosal barrier function in severe burned patients. Burns 2004; 30 (2): 135—139.
67. Coeffer M., Claeyssens S., Hecketsweiler B. et al.Enteral glutamine protein synthesis and decreases ubiquitin mRNA level in human gut mucosa. Am. J. Physiol. Gastrointest. Liver Phisiol. 2003; 285 (2): G266—G273.
68. van der Hulst R. R., van Kreel B. K., von Meyenfeldt M. F. et al.Glutamine and the preservation of gut integrity. Lancet 1993; 341 (8857): 1363—1365.
69. Fox A. D., Kripke S. A., de Paula J. et al.Effect of enteral a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis. J. Parenter. Enteral Nutr. 1988; 12 (4): 325—331.
70. Chun H., Sasaki M., Fujiyama Y., Bamba T.Effect of enteral glutamine on intestinal permeability and bacterial translocation after abdominal radiation injury in rats. J. Gastroenterol. 1997; 32 (2): 189—195.
71. Griffiths R. D,Jones C., Palmer T. E.Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997; 13 (4): 295—302.
72. Dechelotte P., Hasselmann M., Cynober L. et al.L-alanyn-L-glutamine depeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: The
73. French controlled, randomized, double-blind, multicenter study. Crit. Care Med. 2006; 34 (3): 598—604.
74. Goeters C., Wenn A., Mertes N. et al.Parenteral L-alanyl-L-glutamin improves 6-month outcome in critically ill patients Crit. Care Med. 2002; 30 (9): 2032—2037.
75. Novak F., HeylandD. K., Avenell A. et al.Glutamine supplementation in serious illness: A systemic review of the evidence. Crit. Care Med. 2002; 30 (9): 2022—2029.
76. Bongers T., Griffiths R. D., McArdle A. E.Exogenous glutamine: The clinical evidence. Crit. Care Med. 2007; 35 (9 Suppl.): S545—S552.
77. Conejero R., Bonet A., Grau T. et al.Effect of a glutamine-enriched enteral diet on intestinal permeability and infectious morbidity at 28 days in critically patients with systemic inflammatory response syndrome. A randomized, single-blind, prospective, multicenter study. Nutrition 2002; 18 (9): 716—721.
78. Houdijk A. P., Rijnsburger E. R., Jansen J. et al.Randomised trial of glut-amine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 1998; 352 (9130): 772—776.
79. Garrel D., PatenaudeJ., Nedelec B. et al.Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: A prospective, controlled, randomized clinical trial. Crit. Care Med. 2003; 31 (10): 2444—2449.
80. Heyland D., Drover J., Dhaliwal R.Does the addition of glutamine to enteral feeds affect patient mortality? Crit. Care Med. 2006; 34 (7): 2031—2032.
81. McQuiggan M., Kozar R., Sailors R. M. et al.Enteral glutamine during active shock resuscitation is safe and enhances tolerance of enteral feeding. J. Parenter. Enteral Nutr. 2008; 32 (1): 28—35.
82. Beale R. J., Sherry T., Lei K. et al.Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: Outcome of a randomized, controlled double—blind trial. Crit. Care Med. 2008; 36 (1): 131—144.
83. Hall J. C., Dobb G., Hall J. et al.A prospective randomized trial of enter-al glutamine in critical illness. Intensive Care Med. 2003; 29 (10): 1710—1716.
84. Juang P., Fish D. N., Jung R., MacLaren R.Enteral glutamine supplementation in critically ill patients with burn injuries: a retrospective case-control evalution. Pharmacotherapy 2007; 27 (1): 11—19.
85. Schulman A. S., Willcutts K. F., Claridge J. A. et al.Does the addition of glutamine to enteral feeds affect patient mortality? Crit. Care Med. 2005; 33 (11): 2501—2506.
86. Oudemans-van Straaten H. M., Bosman R. J., Treskes M. et al.Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med. 2001; 27 (1): 84—90.
87. Лященко Ю. Н.Искусственное питание в инфузионно-трансфузи-онной терапии неотложных состояний. Автореф. дисс. … докт. мед. наук. Москва; 1998. 52.
88. Wischmeyer P. E.Glutamine: role in critical illness and ongoing clinical trials. Curr. Opin. Gastroenterol. 2008; 24 (2): 190—197.
Рецензия
Для цитирования:
Цветков Д.С. Влияние глутамина на функциональное состояние кишечника у больных в критическом состоянии . Общая реаниматология. 2009;5(3):74. https://doi.org/10.15360/1813-9779-2009-3-74
For citation:
Tsvetkov D.S. Effect of Glutamine on Intestinal Function in Critically Ill Patients . General Reanimatology. 2009;5(3):74. (In Russ.) https://doi.org/10.15360/1813-9779-2009-3-74
Просмотров:
1218
Послать статью по эл. почте 